Skip to main content
OpenTrials

Clinical trial condition

Respiratory Disorders

Explore clinical trials studying Respiratory Disorders. Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Disorders trial results

Completed

Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine

NCT03894969

Conditions
Chronic Disease, DNA Virus Infections, Disease Attributes, +13 more
Locations
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tartu, Estonia
  • GSK Investigational Site Tartu, Estonia
  • GSK Investigational Site Helsinki, Finland
View all 14 locations
View Trial Details
Completed

A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine

NCT03443427

Conditions
Respiration Disorders, Respiratory Disorders, Respiratory Tract Diseases
Locations
  • GSK Investigational Site Truro, Nova Scotia, Canada
  • GSK Investigational Site Sherbrooke, Quebec, Canada
  • GSK Investigational Site Würzburg, Bavaria, Germany
  • GSK Investigational Site Goch, North Rhine-Westphalia, Germany
View Trial Details
Completed

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

NCT03151395

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations
  • GSK Investigational Site Kowloon, Hong Kong
  • GSK Investigational Site Lai Chi Kok, Hong Kong
  • GSK Investigational Site Shatin, Hong Kong
  • GSK Investigational Site Iloilo City, Philippines
View all 19 locations
View Trial Details
Completed

A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

NCT03281876

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Palm Springs, California, United States
View all 67 locations
View Trial Details

Related conditions